Key Takeaway: Consensus sits at a manageable bar — brokerage organic growth of ~4.9% is right in line with management's 5% guide, and adjusted EPS of $1.77 is modestly below the implied run-rate. Risk Management organic growth (guided to 11%) is the bigger swing factor given the upward revision at the June Investor Day.
Table 1 — Current Quarter Snapshot (Q2 2026)
KPI | Q1 2026 Actual | Q2 2025 Actual | Q2 2026 Consensus Estimate | YoY Change | Q2 2026 Guidance | Consensus vs. Guidance |
Adjusted EPS - Diluted - Operating ($) | $4.47 | $2.33 | $1.77 | -24% (Q1 seasonally strongest) | ~$1.80 implied (mgmt commentary) | ~-2% |
Brokerage Organic Revenue Growth (%) | 4.2% | 4.7% | ~4.9% | +20 bps | ~5% | ~-10 bps (in-line) |
Adjusted EBITDAC Margin - Brokerage (%) | 40.1% | 36.4% | ~33.1% | -330 bps (seasonal) | Unchanged from April; 40-60 bps underlying expansion FY | In-line |
Revenue - Brokerage & Risk Mgmt - Operating ($M) | $4,756M | $3,214M | ~$4,023M | +25% (AP acquisition) | N/A (no explicit revenue guide) | N/A |
EBITDAC - Brokerage & Risk Mgmt - Operating ($M) | $1,813M | $1,095M | ~$1,267M | +16% (AP acquisition) | AP EBITDA outlook unchanged from April | In-line |
Risk Management Organic Growth (%) | 10.0% | N/A — not in VA | N/A — not in VA | N/A | ~11% (raised at June Investor Day) | N/A |
Sources: Visible Alpha Consensus and Actuals Data; AJG Q1 2026 Earnings Release (April 30, 2026); AJG Pre-Q2 Investor Meeting (June 17, 2026). All VA-sourced figures cited per Visible Alpha dataset.
Table 2 — Beat/Miss History (Last 8 Quarters, Top 2 KPIs)
KPI 1: Adjusted EPS - Diluted - Operating
Quarter | Reported | Consensus | Surprise % | Result |
Q1 2026 | $4.47 | $4.43 | +0.9% | Beat |
Q4 2025 | $2.38 | $2.32 | +2.6% | Beat |
Q3 2025 | $2.32 | $2.47 | -6.1% | Miss |
Q2 2025 | $2.33 | $2.32 | +0.4% | In-Line / Slight Beat |
Q1 2025 | $3.68 | $3.52 | +4.5% | Beat |
Q4 2024 | $2.13 | $1.99 | +7.0% | Beat |
Q3 2024 | $2.25 | $2.24 | +0.5% | In-Line / Slight Beat |
Q2 2024 | $2.33 | $2.32 | +0.4% | In-Line / Slight Beat |
KPI 2: Brokerage Organic Revenue Growth (%)
Quarter | Reported | Consensus | Surprise (bps) | Result |
Q1 2026 | 4.2% | 4.6% | -40 bps | Slight Miss |
Q4 2025 | 4.5% | 3.4% | +110 bps | Beat |
Q3 2025 | 3.9% | 5.0% | -110 bps | Miss |
Q2 2025 | 4.7% | 5.4% | -70 bps | Slight Miss |
Q1 2025 | 9.1% | 8.4% | +70 bps | Beat |
Q4 2024 | 7.8% | 7.8% | 0 bps | In-Line |
Q3 2024 | 5.4% | 6.2% | -80 bps | Slight Miss |
Q2 2024 | 4.7% | 5.4% | -70 bps | Slight Miss |
Pattern: AJG has a strong track record of beating on adjusted EPS (7 of last 8 quarters), but brokerage organic growth has more frequently come in at or below consensus (5 of last 8 quarters), reflecting the difficulty of forecasting property market pricing dynamics. The Q3 2025 EPS miss was an outlier driven by AssuredPartners integration noise. Source: Visible Alpha Consensus and Actuals Data.
Key Takeaway: Since the April 30 Q1 earnings call, management has raised two key guidance items — AssuredPartners synergy targets (to $325M from $300M) and Risk Management organic growth (to 11% Q2 / 8% FY) — while holding brokerage organic and margin guidance unchanged. Tone has shifted more constructive.
Metric | Initial Guidance (Q1 Earnings Call, Apr 30) | Revised Guidance | Current Consensus | Note |
Brokerage Organic Growth — Q2 2026 | ~5% | — | ~4.9% | Unchanged; CFO stated "further confidence" at June 17 Investor Day |
Brokerage Organic Growth — FY 2026 | ~5.5% | — | ~5.0% | Unchanged; pricing ~1 pt of organic, net new business ~3 pts |
Risk Management Organic Growth — Q2 2026 | ~10% (similar to Q1) | ~11% | N/A — not in VA | ↑ Raised at June 17 Investor Day; driven by large new business wins and international growth |
Risk Management Organic Growth — FY 2026 | ~7% (unchanged from March IR Day) | ~8% | N/A — not in VA | ↑ Raised at June 17 Investor Day; more confident on new business pipeline |
AssuredPartners Synergy Run-Rate (by early 2028) | Up to $300M | Up to $325M | N/A | ↑ Raised at June 17 Investor Day; back-office systems nearly fully implemented, vendor/real estate consolidations ahead of plan |
AssuredPartners EBITDA Outlook — Q2 & FY 2026 | Per April CFO Commentary | — | ~$1,267M (EBITDAC, B&RM) | Unchanged; "integration story continues to improve" |
Brokerage EBITDAC Margin — FY 2026 Underlying Expansion | 40–60 bps underlying expansion | — | ~33.1% Q2 consensus | Unchanged; "no new news" per CFO at June 17 Investor Day |
Share Repurchases — Q2 2026 | In quiet period; no Q2 buybacks at time of Q1 call | ~$170M repurchased in Q2 (disclosed June 17) | N/A | ↑ Disclosed at June 17 Investor Day; opportunistic given management view equity is undervalued |
M&A Pipeline | >40 term sheets, ~$400M annualized revenue | ~40 term sheets, ~$600M annualized revenue | N/A | ↑ Pipeline grew; 15 mergers closed YTD 2026 representing ~$115M annualized revenue |
Sources: AJG Q1 2026 Earnings Call Transcript (April 30, 2026); AJG Pre-Q2 Investor Meeting with Management (June 17, 2026); AJG 8-K (June 17, 2026).
Key Takeaway: Estimates have drifted modestly lower since the Q1 print — Q2 EPS consensus is down ~5% from the post-Q1 baseline — but this appears to reflect dilution from the share repurchase timing and integration noise rather than fundamental deterioration. The gap between current consensus and management's implied trajectory represents a modest cushion heading into the print.
KPI (Period) | Estimate ~5 Days Post Q1 Earnings (May 7, 2026) | Current Consensus (July 29, 2026) | Estimate Δ (%) | Initial Guidance (Q1 Call, Apr 30) | Current Guidance (June 17 Investor Day) | Guidance Δ | Consensus vs. Guidance (%) |
Adj. EPS - Operating (Q2 2026) | $1.86 | $1.77 | -4.8% | ~$1.80 implied | ~$1.80 implied (unchanged) | Flat | ~-2% (slight cushion) |
Brokerage Organic Growth (Q2 2026) | ~4.9% | ~4.9% | Flat | ~5% | ~5% (unchanged; "further confidence") | Flat | ~-10 bps (in-line) |
Adj. EPS - Operating (FY 2026) | $13.21 | $13.14 | -0.5% | N/A (no explicit FY EPS guide) | N/A | N/A | N/A |
Brokerage Organic Growth (FY 2026) | ~5.0% | ~5.0% | Flat | ~5.5% | ~5.5% (unchanged) | Flat | ~-50 bps (modest cushion) |
EBITDAC - B&RM Operating (Q2 2026, $M) | ~$1,269M | ~$1,267M | -0.2% | AP EBITDA unchanged from April | Unchanged | Flat | In-line |
Commentary: The modest ~5% downward drift in Q2 EPS consensus since the Q1 print is largely attributable to the timing of share repurchases (Q2 buybacks of ~$170M were not anticipated at the time of the Q1 call) and integration-related noise, rather than any deterioration in underlying business trends. Brokerage organic growth estimates have been remarkably stable, consistent with management's unchanged 5% Q2 guide. The FY 2026 consensus organic growth of ~5.0% sits ~50 bps below management's 5.5% guide, representing a cushion that could be closed if H2 execution is strong. Source: Visible Alpha Consensus and Actuals Data.
Key Takeaway: AJG has rallied ~30% from its post-Q1 lows, significantly outperforming both the insurance sector ETF (KIE, +15%) and the S&P 500 (+2%) since the April 30 earnings date. The move has been driven almost entirely by multiple re-expansion (EV/EBITDA expanded from ~12x to ~14x over 3 months), not estimate revisions, suggesting the stock has priced in a clean execution story and leaves limited room for disappointment.
AJG vs. KIE (Insurance Sector ETF) vs. S&P 500 — Indexed to 100 at April 30, 2026 (Q1 2026 Earnings Date). Source: Yahoo Finance / Stock Price Data.
Performance Summary (April 30 – July 29, 2026):
Security | Price at Q1 Earnings (Apr 30) | Price (Jul 29, 2026) | Return Since Q1 Earnings |
AJG | $206.40 | ~$268.95 (Jul 28 close) | +30.3% |
KIE (Insurance Sector ETF) | $57.33 | ~$66.45 (Jul 28 close) | +15.9% |
S&P 500 (SPY) | $718.66 | ~$740.86 (Jul 28 close) | +3.1% |
Key Events Since Q1 Earnings:
Valuation Context: AJG currently trades at ~26.6x NTM P/E and ~13.9x NTM EV/EBITDA. The 3-month multiple expansion of ~+16% on EV/EBITDA (from ~12x to ~14x) has been the primary driver of the stock's outperformance, with estimate revisions contributing minimally. This multiple re-rating reflects growing market confidence in the AssuredPartners integration and synergy trajectory, but also raises the bar for the Q2 print. Source: Stock Price Data (Yahoo Finance); Visible Alpha Consensus and Actuals Data.
Key Takeaway: Peer commentary from AON (reported July 29) and BRO (reported July 28) provides a mixed-to-positive read-through for AJG's Q2 print. AON's 5% organic growth beat and reaffirmed guidance is the most directly positive signal; BRO's organic revenue decline of -0.7% is a negative read-through but is heavily distorted by cat property exposure and company-specific factors. All commentary below is strictly from Q2 2026 reporting or post-Q1 2026 commentary about the current quarter.
Note: Only commentary about Q2 2026 (the current reporting period) is included below. Prior-quarter retrospective commentary has been excluded.
Read-Through: POSITIVE
Read-Through: MIXED / NEGATIVE (with important caveats)
Summary Read-Through Table
Peer | Signal | Key Data Point | AJG Read-Through |
AON — Organic Growth (Q2 2026) | POSITIVE | +5% across all segments; beat consensus of ~4.8% | Validates AJG's ~5% brokerage organic guide; demand environment healthy |
AON — Net New Business (Q2 2026) | POSITIVE | 10-pt contribution for 9th consecutive quarter | Supports AJG's ~3 pts net new business contribution to organic growth |
AON — Margin Expansion (Q2 2026) | POSITIVE | +70 bps adjusted operating margin; in-line with FY guide | Positive read-through for AJG's 40–60 bps underlying expansion target |
AON — Reinsurance (Q2 2026) | POSITIVE | +5% organic despite 15–20% lower treaty rates; new business wins offset | Positive for Gallagher Re, which had strong start to 2026 |
AON — Full-Year Guidance (Q2 2026) | POSITIVE | Reaffirmed mid-single-digit or greater organic; 70–80 bps margin expansion | Sector demand environment remains supportive for AJG's FY 5.5% guide |
BRO — Organic Revenue (Q2 2026) | MIXED | -0.7% organic (vs. +0.5% consensus); distorted by litigation, timing, pharmacy | Negative headline but company-specific; AJG less exposed to these factors |
BRO — Cat Property Pricing (Q2 2026) | NEGATIVE | Cat property rates -15% to -35%, similar to Q1 | Confirms property headwind AJG has already guided for; no incremental surprise |
BRO — Casualty Pricing (Q2 2026) | POSITIVE | Primary casualty/professional liability up ~5%; excess under more pressure | Consistent with AJG's casualty data; supports organic growth ex-property |
BRO — H2 2026 Organic Outlook | POSITIVE | Retail 1.5–2.5%, Specialty 2–4% in H2 | Positive for sector H2 momentum; AJG guiding 5–6% in Q3/Q4 |
BRO — Macro / Client Activity (Q2 2026) | NEUTRAL | Stable spending, neutral hiring, positive audit premium activity | Consistent with AJG's mid-June daily revenue indications in "positive territory" |
Sources: AON Q2 2026 Earnings Release and Earnings Call Transcript (July 29, 2026); BRO Q2 2026 Earnings Release and Earnings Call Transcript (July 28, 2026).
Key Takeaway: The most important development since the Q1 print is the June 17 Investor Day, where management raised AssuredPartners synergy targets and Risk Management guidance — a clear positive signal for the Q2 print. The July 29 board change is a neutral governance event.
Key Takeaway: Insider activity since the Q1 earnings print is minimal — only one open-market sale was identified (Controller/CAO Richard Cary, June 2, 2026, $618K, discretionary). The absence of clustered selling or unusual transaction sizes is a neutral-to-positive signal; no open-market buys were filed. The single discretionary sale by the Controller is not a meaningful signal given its modest size relative to the stock's move.
Name | Title | Transaction Type | Value | Date | Note |
Richard C. Cary | Controller, CAO | Open Market Sale | $618,000 (3,000 shares @ ~$206) | June 2, 2026 | Discretionary sale; no 10b5-1 plan indicated. Modest size; sold near post-Q1 lows. Not a meaningful signal. |
Note: The remaining Form 4 filings reviewed for the period (17 total filings) consisted of equity award grants, vesting events, and tax withholding transactions — not open-market buys or sells. No 10b5-1 plan initiations were identified in the review period. The absence of insider buying despite management's stated view that equity is "woefully undervalued" is notable but may reflect the company's quiet period policy and ongoing M&A activity. Source: SEC Form 4 filings (AJG, April 30 – July 29, 2026).